US Eq Undivided
Payments companies reported to CMS as associated with US Eq Undivided. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with US Eq Undivided, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with US Eq Undivided
These are the largest totals companies reported as associated with US Eq Undivided. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jasvindar Singh | Saint Louis, MO | Interventional Cardiology | $22,500.00 |
| Micah Watts | Galloway, NJ | Vascular & Interventional Radiology | $15,656.00 |
| Matthew Chung | Richmond, VA | Interventional Cardiology | $15,226.51 |
| Karim Al-Azizi | Plano, TX | Interventional Cardiology | $13,059.09 |
| Paul Gagne | Darien, CT | Vascular Surgery | $13,026.52 |
| Sreekumar Madassery | Chicago, IL | Vascular & Interventional Radiology | $10,500.00 |
| Jimmy Kerrigan | Nashville, TN | Interventional Cardiology | $9,190.32 |
| Jean Panneton | Virginia Beach, VA | Vascular Surgery | $9,084.37 |
| Sameh Sayfo | Plano, TX | Interventional Cardiology | $8,812.32 |
| Siddhartha Rao | Cary, NC | Interventional Cardiology | $8,800.00 |
Prescribed US Eq Undivided?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.